194 related articles for article (PubMed ID: 8289205)
1. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization, and in vitro evaluation of nitroimidazole--BATO complexes: new technetium compounds designed for imaging hypoxic tissue.
Linder KE; Chan YW; Cyr JE; Nowotnik DP; Eckelman WC; Nunn AD
Bioconjug Chem; 1993; 4(5):326-33. PubMed ID: 8274515
[TBL] [Abstract][Full Text] [Related]
3. Improving tumor/muscle and tumor/blood ratios of
Li S; Chu T
Bioorg Med Chem Lett; 2023 Feb; 82():129154. PubMed ID: 36736496
[TBL] [Abstract][Full Text] [Related]
4. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
5. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of two technetium-99m-labeled peptidic 2-nitroimidazoles for imaging hypoxia.
Su ZF; Zhang X; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 1999; 10(5):897-904. PubMed ID: 10502359
[TBL] [Abstract][Full Text] [Related]
8. Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: effect of lipophilicity.
Zhang X; Su ZF; Ballinger JR; Rauth AM; Pollak A; Thornback JR
Bioconjug Chem; 2000; 11(3):401-7. PubMed ID: 10821657
[TBL] [Abstract][Full Text] [Related]
9. Technetium(V) oxo complexes of substituted propylene diamine dioxime (PnAO) ligands: water-dependent interconversion between syn and anti isomers.
Cyr JE; Nowotnik DP; Pan Y; Gougoutas JZ; Malley MF; Di Marco J; Nunn AD; Linder KE
Inorg Chem; 2001 Jul; 40(14):3555-61. PubMed ID: 11421705
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
11. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents.
Mastrostamatis SG; Papadopoulos MS; Pirmettis IC; Paschali E; Varvarigou AD; Stassinopoulou CI; Raptopoulou CP; Terzis A; Chiotellis E
J Med Chem; 1994 Sep; 37(20):3212-8. PubMed ID: 7932548
[TBL] [Abstract][Full Text] [Related]
12. A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart.
Rumsey WL; Cyr JE; Raju N; Narra RK
Biochem Biophys Res Commun; 1993 Jun; 193(3):1239-46. PubMed ID: 8323545
[TBL] [Abstract][Full Text] [Related]
13. Nitroimidazoles and hypoxia imaging: synthesis of three technetium-99m complexes bearing a nitroimidazole group: biological results.
Riché F; d'Hardemare AD; Sèpe S; Riou L; Fagret D; Vidal M
Bioorg Med Chem Lett; 2001 Jan; 11(1):71-4. PubMed ID: 11140737
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro and in vivo characterization of novel 99mTc-'4+1'-labeled 5-nitroimidazole derivatives as potential agents for imaging hypoxia.
Giglio J; Fernández S; Pietzsch HJ; Dematteis S; Moreno M; Pacheco JP; Cerecetto H; Rey A
Nucl Med Biol; 2012 Jul; 39(5):679-86. PubMed ID: 22534030
[TBL] [Abstract][Full Text] [Related]
15. The synthesis and in vitro evaluation of a 99mtechnetium-nitroimidazole complex based on a bis(amine-phenol) ligand: comparison to BMS-181321.
Ramalingam K; Raju N; Nanjappan P; Linder KE; Pirro J; Zeng W; Rumsey W; Nowotnik DP; Nunn AD
J Med Chem; 1994 Nov; 37(24):4155-63. PubMed ID: 7990115
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
17. Modeling novel radiopharmaceuticals: mono-C6-substituted PnAO ligands (PnAO = 3,3,9,9-tetramethyl-4,8-diazaundecane-2,10-dione dioxime).
Walker PS; Bergin PM; Grossel MC; Horton PN
Inorg Chem; 2004 Jul; 43(14):4145-53. PubMed ID: 15236526
[TBL] [Abstract][Full Text] [Related]
18. [99mTc]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia.
Kumar P; Wiebe LI; Mannan RH; Zhang Z; Xia H; McEwan AJ
Appl Radiat Isot; 2002 Nov; 57(5):719-28. PubMed ID: 12433047
[TBL] [Abstract][Full Text] [Related]
19. A novel amine-dioxime chelator for technetium-99m: synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells.
Su ZF; Ballinger JR; Rauth AM; Abrams DN; Billinghurst MW
Bioconjug Chem; 2000; 11(5):652-63. PubMed ID: 10995208
[TBL] [Abstract][Full Text] [Related]
20. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
